Modelos europeos de telemedicina, como el servicio finlandés Medilux, permiten realizar consultas médicas online mediante un cuestionario clínico, sin acudir a una consulta presencial.

OCT in STEMI Patients: Is It Safe to Prevent Stenting?

Percutaneous coronary intervention in patients with acute myocardial infarction (AMI) where the physiopathological mechanism is plaque erosion or non-atherosclerotic mechanisms (such as spontaneous coronary artery dissection) is not beneficial according to recent studies. 

OCT en pacientes con SCACEST, ¿Es seguro utilizarlo para evitar implante de stent?

The EROSION study (Effective Anti-Thrombotic Therapy Without Stenting: Intravascular Optical Coherence Tomography–Based Management in Plaque Erosion) has shown medical treatment with no stenting might be an option to treat plaque erosion driven AMI. To assess the etiological differences generated by a coronary event using optical coherence tomography (OCT) is ideal.

The aim of this multicenter, prospective, randomized study in STEMI patients followed up at one year, was to examine whether OCT guided revascularization is associated with lower stenting rate vs. conventional angiography guided revascularization. 

Primary effectiveness end point was stent implantation rate in both groups. Safety end point was incidence of the composite of cardiovascular death, repeat MI, target vessel revascularization and unstable angina. Secondary end point included the incidence of cerebro and cardiovascular events at 1 year. 

226 patients were included, 112 in the OCT group and 114 in the angiography group. Mean age was 55, mostly were men. Culprit lesion was most frequently located in the anterior descending (49%) and right coronary arteries (40%).

Read also: RESTORE | Using Rivaroxaban to Prevent Radial Artery Occlusion After an Intervention.

Total stent implantation rate was 51%, OCT presenting the lowest rate compared against the angiography group (43.8% vs 58.8%; P = 0.024). there were no significant differences in secondary end point. 

Conclusion

In STEMI patients with early infarct artery patency with no significative stenosis compared against the angiography guided group, OCT reduced stent implantation rate.  Further study is required to determine the clinical benefits of OCT guided reperfusion.

Dr. Andrés Rodríguez
Member of the Editorial Board in SOLACI.org .

Original Title: EROSION III A Multicenter RCT of OCT-Guided Reperfusion in STEMI With Early Infarct Artery Patency.

Reference: Haibo Jia, MD, PHD et al. J Am Coll Cardiol Intv 2022.


Subscribe to our weekly newsletter

Get the latest scientific articles on interventional cardiology

More articles by this author

EuroPCR 2026 | 10-Year Left Main PCI: When Survival Is Similar, Should the Less Invasive Strategy Prevail?

The primary goal of revascularization in left main coronary artery disease (LMCA) is to improve survival. However, debate continues regarding whether, in anatomically suitable...

EuroPCR 2026 | TAVI and Coronary Artery Disease: FFR-Guided PCI Showed Better Outcomes Than an Angiography-Guided Strategy

In patients undergoing TAVI, the concomitant presence of coronary artery disease continues to generate debate: whether coronary lesions should be treated before, during, or...

EuroPCR 2026 | Evolocumab Reduces Cardiovascular Events in Patients With Prior PCI Without Previous Myocardial Infarction: VESALIUS-CV Results

This presentation, delivered by Dr. Brian A. Bergmark and colleagues at EuroPCR 2026, detailed the results of the VESALIUS-CV trial, focusing specifically on the...

EuroPCR 2026 | Is It Safe to Stop Aspirin After One Month in MI Patients Undergoing PCI? TARGET-FIRST Analysis

This is a summary of the post-hoc analysis of the TARGET-FIRST study, presented by Dr. Giuseppe Tarantini at EuroPCR 2026, evaluating early aspirin discontinuation...

LEAVE A REPLY

Please enter your comment!
Please enter your name here

Related Articles

SOLACI Sessionsspot_img
Jornadas Guatemala 2026

Recent Articles

EuroPCR 2026 | TAVI in Women: Do Supra-Annular Valves Offer a True Hemodynamic Advantage?

Women represent a particularly challenging population for TAVI, as they often have smaller aortic annuli, greater frailty, and an increased risk of prosthesis-patient mismatch....

EuroPCR 2026 | TAVI or Surgery in Younger Patients? Quality of Life and 3-Year Outcomes from NOTION-2

The expansion of TAVI into younger and lower surgical-risk populations has sparked a new debate: beyond mortality and stroke, which strategy provides better functional...

EuroPCR 2026 | MELA Registry: Myval Showed Lower Aortic Regurgitation Rates in Patients With Large Aortic Annuli

This presentation, delivered by Dr. Salvatore Giordano at EuroPCR 2026, detailed the results of the MELA Registry, a multicenter study comparing the performance of...